[Childhood craniopharyngioma with hypothalamic obesity - no long-term weight reduction due to rehabilitation

A S Sterkenburg1, A Hoffmann2, U Gebhardt2

  • 1University Medical Center (UMCG), University of Groningen, Groningen, Netherlands.

Klinische Padiatrie
|November 29, 2014
PubMed

Insights

Rehabilitation efforts did not show long-term weight reduction in childhood craniopharyngioma survivors with hypothalamic obesity. Further research is needed to improve treatment strategies and patient prognosis.

Area of Science:

  • Pediatric Endocrinology
  • Neuro-oncology
  • Obesity Research

Context:

  • Childhood craniopharyngioma survivors often develop severe obesity due to hypothalamic damage.
  • Long-term effects of rehabilitation on weight management in these patients remain under-analyzed.

Purpose:

  • To analyze the long-term weight development in childhood craniopharyngioma survivors after rehabilitation interventions.
  • To evaluate the effectiveness of rehabilitation in managing hypothalamic obesity in this patient cohort.

Summary:

  • This study analyzed 108 childhood craniopharyngioma patients, with 31 undergoing rehabilitation for hypothalamic obesity.
  • Patients receiving rehabilitation had higher BMIs at diagnosis and follow-up compared to those without.
  • No significant long-term weight-reducing effect of rehabilitation was detected, irrespective of obesity severity or rehabilitation frequency.

Impact:

  • Current rehabilitation options for hypothalamic obesity in craniopharyngioma survivors are limited.
  • Future strategies should focus on preventing hypothalamic lesions and addressing psychosocial aspects of rehabilitation to improve long-term outcomes.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
1
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
13